Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset
- 1 May 1992
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 42 (1) , 75-83
- https://doi.org/10.1016/0091-3057(92)90449-p
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- 5‐HT1A agonists increase and 5‐HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely‐moving guinea‐pigsBritish Journal of Pharmacology, 1990
- The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primatesPharmacology Biochemistry and Behavior, 1990
- Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic studyEuropean Journal of Pharmacology, 1989
- Effect of 5‐hydroxytryptamine on [3H]‐acetylcholine release from guinea‐pig striatal slicesBritish Journal of Pharmacology, 1989
- Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominataNeuroscience Letters, 1989
- 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissueNature, 1989
- Activation of a 5-HT3 receptor releases dopamine from rat striatal sliceEuropean Journal of Pharmacology, 1988
- Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's DiseaseJournal of Neurochemistry, 1988
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Memory Deficits in Aged Cebus Monkeys and Facilitation With Central CholinomimeticsNeurobiology of Aging, 1980